Classification of human ovarian tumors using multivariate data analysis of polypeptide expression patterns

International Journal of Cancer

Volumn 86, Issue 5, 2000, Pages 731-736

  Alaiya, Ayodele A ^a   Franzén, Bo ^b   Hagman, Anders ^b   Silfverswärd, Claes ^a   Moberger, Birgitta ^a   Linder, Stig ^a   Auer, Gert ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Astra Arcus AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; POLYPEPTIDE;

ARTICLE; ARTIFICIAL INTELLIGENCE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MULTIVARIATE ANALYSIS; OVARY TUMOR; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; TUMOR CLASSIFICATION;

BREAST NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; PEPTIDE MAPPING; PEPTIDES; TUMOR CELLS, CULTURED;

EID: 0034017342     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000601)86:5<731::AID-IJC20>3.0.CO;2-A     Document Type: Article

References (24)

1. ALAIYA, A.A., FRANZÉN, B., FUJIOKA, K., MOBERGER, B., SCHEDVINS, K., SILVERSVÄRD, C., LINDER, S. and AUER, G., Phenotypic analysis of ovarian carcinoma: polypeptide expression in benign, borderline and malignant tumors. Int. J. Cancer, 73, 678-683 (1997).
2. ALAIYA, A.A., FRANŹEN, B. LINDER, S. and AUER, G., Two-dimensional gel electrophoresis of protein expression in ovarian tumors suggest a low degree of intratumor heterogeneity. Electrophoresis, 20, 1039-1046 (1999).
3. DALTON, L.W., PAGE, D.L. and DUPONT, W.D. Histological grading of breast carcinomas. A reproducibility study. Cancer, 73, 2765-2770 (1994).
4. DAWSON, A.E., AUSTIN, R.E.J. and WEINBERG, D.S., Nuclear grading of breast carcinoma by image analysis. Classification by multivariate and neural network analysis. J. clin. Pathol., 95, 29-37 (1991).
5. ERLER, B.S., HSU, L., TRUONG, H.M., PETROVIC, L.M., KIM, S.S., HUH, M.H., FERRELL, L.D., THUNG, S.N., GELLER, S.A. and MARCHEVSKY, A.M., Image analysis and diagnostic classification of hepatocellular carcinoma using neural networks and multivariate discriminant functions. Lab. Invest., 71, 446-451 (1994).
6. FRANZÉN, B., AUER, G., ALAIYA, A.A., ERIKSSON, E., URYU, K., HIRANO, T., OKUZAWA, K., KATO, H. and LINDER, S., Assessment of homogeneity in polypeptide expression shows highly variable expression in high malignant breast carcinomas. Int. J. Cancer, 69, 408-414 (1996a).
7. FRANZÉN, B., AUER, G., ALAIYA, A.A., ERIKSSONS, E., URYU, K., HIRANO, T, OKUZAWA, K. and LINDER, S., Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins. Brit. J. Cancer, 73, 1632-1638 (1996b).
8. FRANZÉN, B. OKUZAWA, K., LINDER, S., KATO, H. and AUER, G., Nonenzymatic extraction of cells from clinical tumour material for analysis of gene expression hy two-dimensional gel electrophoresis. Electrophoresis, 14, 382-390 (1993).
9. FRIEDLANDER, M.L., Prognostic factors in ovarian cancer. Semin. Oncol., 25, 305-314 (1998).
10. GARRELS, J.I., The QUEST system for quantitative analysis of two-dimensional gels. J. biol. Chem, 264, 5269-5282 (1989).
11. GELADI, P. and KOWALSKI, B.R., Partial least squares regression: a tutorial. Anal. Chim. Acta., 185, 1-17 (1986).
12. GOLDSCHMIDT, D., DECAESTECKER, C., BERTHE, J.V., GORDOWER, L., REMMELINK, M., DANGUY, A., PASTEELS, J.L., SALMON, I. and KISS, R., The contribution of image cytometry and artificial intelligence-related methods of numerical data analysis for adipose tumor histopathologic classification. Lab. Invest., 75, 295-306 (1996).
13. HÖSKULDSSON, A., PLS regression methods. J. Chemometrics, 2, 211 (1988).
14. JOCLIFFE, I.T., Principal component analysis, Springer. New York (1986).
15. KRONQVIST, P., MONTIRONI, R., KUOPIO, T. and COLLAN, Y.U., Subjective breast cancer grading. Analyses of reproducibility after application of Bayesian belief networks. Anal. quant. Cytol. Histol., 19, 423-429 (1997).
16. LINK, C.J.J., REED, E., SAROSY, G. and KOHN, E.C., Borderline ovarian tumors. Amer. J. Med., 101, 217-225 (1996).
17. PARTRIDGE, E.E., PHILLIPS, J.L. and MENCK, H.R., The National Cancer Data Base report on ovarian cancer treatment in United States hospitals. Cancer, 98, 2236-2246 (1996).
18. RABILLOUD, T., VUILLARD, L., GILLY, C. and LAWRENCE, J.-J., Silver-staining of proteins in polyacrylamide gels: a general overview. Cell mol. Biol., 57-75 (1994).
19. RAVDIN, P.M., CLARK, G.M., HILSENBECK, S.G., OWENS, M.A., VENDELY, P., PANDIAN, M.R. and MCGUIRE, W.L., A demonstration that breast cancer recurrence can be predicted by neural network analysis. Breast Cancer Res. Treat., 21, 47-53 (1992).
20. SCHMID, H.R., SCHMITTER, D., BLUM, P., MILLER, M. and VONDER-SCHMITT, D., Lung tumor cells: a multivariate approach to cell classification using two-dimensional protein pattern. Electrophoresis, 16, 1961-1968 (1995).
21. SCULLY, R.E., World Health Organization classification and nomenclature of ovarian cancer. Nat. Cancer Inst. Monogr., 42, 5-7 (1975).
22. SPANAKIS, E. and BROUTY-BOYÉ, D., Discrimination of fibroblast subtypes by multivariate analysis of gene expression. Int. J. Cancer, 71, 402-409 (1997).
23. TEWARI, A. and NARAYAN, P., Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks. J. Urol., 160, 430-436 (1998).
24. WILKINS, M.R., HOCHSTRASSER, D.F., SANCHEZ, J.C., BAIROCH, A. and APPEL, R.D., Integrating two-dimensional gel databases using the Melanie II software. Trends biochem. Sci., 21, 496-497 (1996).